Vergent Bioscience
Jeff Julkowski has been working in the business industry since 1995. Jeff began their career at Salomon Smith Barney, where they held two positions as a Security Analyst. In 2001, they became the President and Owner of KR Group. Three years later, they Co-founded Chamilia and served as the company's CEO. In 2013, they Co-founded The SEED Partners and in 2016, they became the Director and Co-founder of Vergent Bioscience.
Jeff Julkowski attended the United States Military Academy at West Point, where they earned a Bachelor of Science in Engineering Management. Jeff then went on to pursue an MBA in Finance from Cameron University.
This person is not in any teams
This person is not in any offices
Vergent Bioscience
Vergent Bioscience is a biotech company leading the development of tumor-targeted molecular imaging molecules for cancer surgery.